Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022 - Product Image

Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022

  • ID: 4376271
  • Report
  • Region: Global
  • 223 Pages
  • Markets and Markets
1 of 6
The global biopsy devices market is projected to reach USD 2.42 billion by 2022 from USD 1.74 billion in 2017, at a CAGR of 6.8% during the forecast period.

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Hologic, INC.
  • Inrad, Inc.
  • MORE

“The global biopsy devices market is projected to grow at a CAGR of 6.8%.”

The global biopsy devices market is projected to reach USD 2.42 billion by 2022 from USD 1.74 billion in 2017, at a CAGR of 6.8% during the forecast period. The significant increase in the number of people who have cancer, growing number minimally invasive biopsies, and government initiatives in various countries & global health organizations are the major factors responsible for the growth of the biopsy devices market during the forecast period. However, factors such as patient safety risks associated with biopsy devices leading to product recalls and risk of infections related to biopsy procedures are expected to hinder the growth of this market to a certain extent.

“The needle-based biopsy instruments segment is expected to grow at the fastest rate during the forecast period.”

By product, the global biopsy devices market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products such as forceps, markers, probes, punches, curettes, and sutures. The needle-based biopsy instruments segment is expected to register the highest CAGR during the forecast period owing to increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.

“The breast biopsy segment dominated the biopsy devices market in 2016.”

On the basis of application, the biopsy devices market is segmented into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. In 2016, the breast biopsy segment accounted for the major share of the global biopsy devices market. This is primarily due to the rising prevalence of breast cancer and growing awareness of the disease.

“Stereotactic-guided biopsy segment to witness the highest growth during the forecast period.”

On the basis of guidance technique, the biopsy devices market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging (MRI)-guided biopsy, and other guidance techniques (positron emission tomography, fluoroscopy, and thermography). The stereotactic-guided segment is expected to register for the highest CAGR during the forecast period. This is primarily due to the advantage of this guidance technique in evaluating even tiny masses which are not visible on ultrasound; moreover, it is a cost-effective procedure as compared to open surgical biopsies and leaves fewer scars with almost no pain.

“APAC to witness the highest growth during the forecast period.”

Geographically, the global biopsy devices market is broadly segmented into five major geographies, namely, North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East & Africa. In 2016, North America commanded a major share of the global biopsy devices market. However, Asia-Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia-Pacific market is mainly attributed to the large population in countries like China and India, rising prevalence and awareness of cancer, improving healthcare infrastructure, increasing healthcare spending, increasing per capita income, government initiatives, and rising focus of key market players in the region.

Break of primary participants was as mentioned below:

  • By Company Type – Tier 1–42%, Tier 2–38% and Tier 3–20%
  • By Designation – C-level–40%, Director Level–35%, Others–25%
  • By Region – North America–35%, Europe–30%, Asia-Pacific–20%, RoW–15%

Some of the prominent players in the biopsy devices market include C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland).

Research Coverage:

The report analyzes the various types of biopsy devices in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the biopsy devices market for different segments such as product, guidance technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies for strengthening their market position.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the biopsy devices market
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the biopsy devices market
  • Market Development: Comprehensive information about lucrative emerging markets by product, guidance technique, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the biopsy devices market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the biopsy devices market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Hologic, INC.
  • Inrad, Inc.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Biopsy Devices: Market Overview
4.2 Biopsy Devices Market: Developed vs Developnig Countries
4.3 Geographic Snapshot: Biopsy Devices Market (2016)
4.4 Biopsy Devices Market, By Product (2017 vs 2022)
4.5 Biopsy Devices Market : Geographic Mix

5 Market Overview
5.1 Key Market Dynamics
5.1.1 Market Drivers
5.1.1.1 Rising Prevalence of Cancer
5.1.1.2 Increasing Preference for Minimally Invasive Surgeries
5.1.1.3 Initiatives Undertaken By Government and Global Health Organizations
5.1.1.4 Improved Reimbursement Scenario in U.S.
5.1.2 Market Restraints
5.1.2.1 Product Recalls
5.1.2.2 Risk of Infections
5.1.3 Market Opportunities
5.1.3.1 Emerging Economies
5.1.4 Market Challenges
5.1.4.1 Underdeveloped Healthcare Infrastructure and Dearth of Resources in Developing Countries
5.2 Industry Trends
5.2.1 Emergence of Liquid Biopsy
5.2.2 Development of Fully Integrated Biopsy Devices
5.3 Regulatory Analysis
5.3.1 North America
5.3.1.1 U.S.
5.3.2 Europe
5.3.3 APAC
5.3.3.1 Japan
5.3.3.2 China
5.3.3.3 India
5.3.4 Latin America
5.3.4.1 Brazil
5.3.4.2 Mexico
5.3.4.3 Colombia

6 Global Biopsy Devices Market, By Product
6.1 Introduction
6.2 Needle-Based Biopsy Instruments
6.2.1 Core Biopsy Devices
6.2.2 Aspiration Biopsy Needles
6.2.3 Vacuum-Assisted Biopsy Devices
6.3 Procedure Trays
6.4 Localization Wires
6.5 Other Products

7 Global Biopsy Devices Market, By Application
7.1 Introduction
7.2 Breast Biopsy
7.3 Lung Biopsy
7.4 Colorectal Biopsy
7.5 Prostate Biopsy
7.6 Other Applications

8 Global Biopsy Devices Market, By Guidance Technique
8.1 Introduction
8.2 Ultrasound-Guided Biopsy
8.3 Stereotactic-Guided Biopsy
8.4 Mri-Guided Biopsy
8.5 Other Guidance Techniques

9 Global Biopsy Devices Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Academic and Research Institutes
9.4 Diagnostic and Imaging Centers

10 Biopsy Devices Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Latin America
10.6 Middle East and Africa

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Emerging Companies
11.3.4 Dynamic Differentiators
11.4 Competitive Benchmarking
11.4.1 Strength of Product Portfolio (26 Players)
11.4.2 Business Strategyexcellence (26 Players)

12 Company Profiles
12.1 C. R. Bard, Inc.
12.2 Becton, Dickinson and Company
12.3 Cook Group Incorporated
12.4 Devicor Medical Products, Inc. (A Part of Leica Biosystems)
12.5 Argon Medical Devices, Inc.
12.6 B. Braun Melsungen AG
12.7 Cardinal Health, Inc.
12.8 Olympus Corporation
12.9 Boston Scientific Corporation
12.10 Fujifilm Holdings Corporation
12.11 Inrad, Inc.
12.12 Medtronic PLC
12.13 Hologic, INC.

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details

List of Tables:
Table 1 Comparison of Reimbursement for Biopsy Procedures, 2015 vs 2017
Table 2 Reimbursement for Biopsy Procedures, 2017
Table 3 Indicative List of FDA Product Recalls for Biopsy Devices (2016–2017)
Table 4 Biopsy Devices Under 21 Cfr 876.1075 With Product Codes
Table 5 Classification of Medical Devices and the Reviewing Body in Japan
Table 6 Nomenclature of Applicable Medical Devices With Codes
Table 7 Regulatory Classification for Medical Devices in India
Table 8 Brazil: Time, Cost, and Complexity of the Registration Process
Table 9 Mexico: Time, Cost, and Complexity of Registration Process
Table 10 Colombia: Time, Cost, and Complexity of Registration Process
Table 11 Global Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 12 Global Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 13 Global Needle-Based Biopsy Instruments Market, By Country/Region, 2015–2022 (USD Million)
Table 14 Major Brands of Core Biopsy Devices
Table 15 Global Core Biopsy Devices Market, By Country/Region, 2015–2022 (USD Million)
Table 16 Global Core Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 17 Global Core Biopsy Guns Market, By Country/Region, 2015–2022 (USD Million)
Table 18 Global Core Biopsy Needles Market, By Country/Region, 2015–2022 (USD Million)
Table 19 Major Brands of Aspiration Biopsy Needles
Table 20 Global Aspiration Biopsy Needles Market, By Country/Region, 2015–2022 (USD Million)
Table 21 Major Brands of Vacuum-Assisted Biopsy Devices
Table 22 Global Vacuum-Assisted Biopsy Devices Market, Region/Country, 2015–2022 (USD Million)
Table 23 Global Vacuum-Assisted Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 24 Global Vacuum-Assisted Biopsy Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 25 Global Vacuum-Assisted Biopsy Needles Market, By Country/Region, 2015–2022 (USD Million)
Table 26 Global Procedure Trays Market, By Country/Region, 2015–2022 (USD Million)
Table 27 Major Brands of Localization Wires
Table 28 Global Localization Wires Market Size, By Country/Region, 2015–2022 (USD Million)
Table 29 Global Other Biopsy Products Market, By Country/Region, 2015–2022 (USD Million)
Table 30 Global Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 31 Global Biopsy Devices Market for Breast Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 32 Global Biopsy Devices Market for Lung Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 33 Global Biopsy Devices Market for Colorectal Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 34 Global Biopsy Devices Market for Prostate Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 35 Global Biopsy Devices Market for Other Applications, By Country/Region, 2015–2022 (USD Million)
Table 36 Global Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 37 Global Biopsy Devices Market for Ultrasound-Guided Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 38 Global Biopsy Devices Market for Stereotactic-Guided Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 39 Global Biopsy Devices Market for Mri-Guided Biopsy, By Country/Region, 2015–2022 (USD Million)
Table 40 Global Biopsy Devices Market for Other Guidance Techniques, By Country/Region, 2015–2022 (USD Million)
Table 41 Global Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 42 Number of Hospitals, By Region (2010 vs 2014)
Table 43 Global Biopsy Devices Market for Hospitals, By Country/Region, 2015–2022 (USD Million)
Table 44 Global Biopsy Devices Market for Academic and Research Institutes, By Country/Region, 2015–2022 (USD Million)
Table 45 Global Biopsy Devices Market for Diagnostic and Imaging Centers, By Country/Region, 2015–2022 (USD Million)
Table 46 Biopsy Devices Market, By Region, 2015–2022 (USD Million)
Table 47 North America: Biopsy Devices Market, By Country, 2015–2022 (USD Million)
Table 48 North America: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 49 North America: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 50 North America: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 51 North America: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 52 North America: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 53 North America: Biopsy Devices Market, By Guiding Technique, 2015–2022 (USD Million)
Table 54 North America: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 55 Estimated New Cases of Cancer in 2017
Table 56 Key Market Indicators: U.S.
Table 57 U.S.: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 58 U.S.: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 59 U.S.: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 60 U.S.: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 61 U.S.: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 62 U.S.: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 63 U.S.: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 64 Key Market Indicators: Canada
Table 65 Overview of the Breast, Cervical, and Colorectal Cancer Screening Programs Across Canada
Table 66 Canada: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 67 Canada: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 68 Canada: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 69 Canada: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 70 Canada: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 71 Canada: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 72 Canada: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 73 Europe: Biopsy Devices Market, By Country 2015–2022 (USD Million)
Table 74 Europe: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 75 Europe: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 76 Europe: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 77 Europe: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 78 Europe: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 79 Europe: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 80 Europe: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 81 Key Market Indicators: Germany
Table 82 Germany: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 83 Germany: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 84 Germany: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 85 Germany: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 86 Germany: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 87 Germany: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 88 Germany: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 89 Key Market Indicators: France
Table 90 France: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 91 France: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 92 France: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 93 France: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 94 France: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 95 France: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 96 France: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 97 Key Market Indicators: U.K.
Table 98 U.K.: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 99 U.K.: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 100 U.K.: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 101 U.K.: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 102 U.K.: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 103 U.K.: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 104 U.K.: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 105 Key Market Indicators: Italy
Table 106 Italy: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 107 Italy: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 108 Italy: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 109 Italy: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 110 Italy: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 111 Italy: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 112 Italy: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 113 Key Market Indicators: Spain
Table 114 Spain: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 115 Spain: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 116 Spain: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 117 Spain: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 118 Spain: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 119 Spain: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 120 Spain: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 121 RoE: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 122 RoE: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 123 RoE: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 124 RoE: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 125 RoE: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 126 RoE: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 127 RoE: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 128 APAC: Biopsy Devices Market, By Country, 2015–2022 (USD Million)
Table 129 APAC: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 130 APAC: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 131 APAC: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 132 APAC: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 133 APAC: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 134 APAC: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 135 APAC: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 136 Key Market Indicators: Japan
Table 137 Japan: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 138 Japan: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 139 Japan: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 140 Japan: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 141 Japan: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 142 Japan: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 143 Japan: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 144 Key Market Indicators: China
Table 145 China: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 146 China: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 147 China: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 148 China: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 149 China: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 150 China: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 151 China: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 152 Key Market Indicators: India
Table 153 India: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 154 India: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 155 India: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 156 India: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 157 India: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 158 India: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 159 India: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 160 RoAPAC: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 161 RoAPAC: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 162 RoAPAC: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 163 RoAPAC: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 164 RoAPAC: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 165 RoAPAC: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 166 RoAPAC: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 167 Latin America: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 168 Latin America: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 169 Latin America: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 170 Latin America: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 171 Latin America: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 172 Latin America: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 173 Latin America: Biopsy Devices Market, By End User, 2015–2022 (USD Million)
Table 174 Middle East and Africa: Biopsy Devices Market, By Product, 2015–2022 (USD Million)
Table 175 Middle East and Africa: Needle-Based Biopsy Instruments Market, By Type, 2015–2022 (USD Million)
Table 176 Middle East and Africa: Core Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 177 Middle East and Africa: Vacuum-Assisted Biopsy Devices Market, By Type, 2015–2022 (USD Million)
Table 178 Middle East and Africa: Biopsy Devices Market, By Application, 2015–2022 (USD Million)
Table 179 Middle East and Africa: Biopsy Devices Market, By Guidance Technique, 2015–2022 (USD Million)
Table 180 Middle East and Africa: Biopsy Devices Market, By End User, 2015–2022 (USD Million)

List of Figures:
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Biopsy Market, By Product, 2017 vs 2022 (USD Billion)
Figure 7 Global Biopsy Devices Market, By Application, 2017 vs 2022 (USD Billion)
Figure 8 Global Biopsy Devices Market, By Guidance Technique, 2017 vs 2022 (USD Billion)
Figure 9 Global Biopsy Devices Market, By End User, 2017 vs 2022 (USD Billion)
Figure 10 Geographic Snapshot: Biopsy Devices Market
Figure 11 Increasing Prevalence of Cancer is the Key Market Driver for Biopsy Devices
Figure 12 Developing Markets to Register Higher Growth During the Forecast Period
Figure 13 U.S. Accounted for the Largest Share of the Biopsy Devices Market in 2016
Figure 14 Needle-Based Biopsy Instruments Will Continue to Dominate the Biopsy Devices Market in 2022
Figure 15 North America to Dominate the Global Biopsy Devices Market During the Forecast Period
Figure 16 Biopsy Devices Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Cancer Prevalence and Mortality Rate, By Country, 2012
Figure 18 Increasing Cancer Prevalence in the Geriatric Population (2012–2030)
Figure 19 CE Mark Approval Process for Biopsy Devices in Europe
Figure 20 Regulatory Process for Medical Devices in Brazil
Figure 21 Regulatory Process for Medical Devices in Mexico
Figure 22 Regulatory Process for Medical Devices in Colombia
Figure 23 Global Biopsy Devices Market, By Product, 2017 vs 2022 (USD Million)
Figure 24 Breast Biopsy to Dominate the Biopsy Devices Market in 2017
Figure 25 Ultrasound-Guided Biopsy to Dominate the Biopsy Devices Market During the Forecast Period
Figure 26 Hospitals Will Continue to Dominate the Biopsy Devices Market in 2022
Figure 27 Biopsy Devices Market: Geographic Growth Opportunities
Figure 28 North America: Biopsy Devices Market Snapshot
Figure 29 Canada: Cancer Statistics
Figure 30 Europe: Biopsy Devices Market Snapshot
Figure 31 APAC: Biopsy Devices Market Snapshot
Figure 32 Global Biopsy Devices Market Share Analysis, By Key Player, 2016
Figure 33 Biopsy Devices Market (Global), Competitive Leadership Mapping, 2017
Figure 34 C.R. Bard, Inc.: Company Snapshot
Figure 35 Becton, Dickinson and Company: Company Snapshot
Figure 36 Danaher Corporation: Company Snapshot
Figure 37 B. Braun Melsungen AG: Company Snapshot
Figure 38 Cardinal Health, Inc.: Company Snapshot
Figure 39 Olympus Corporation: Company Snapshot
Figure 40 Boston Scientific Corporation: Company Snapshot
Figure 41 Fujifilm Holdings Corporation: Company Snapshot
Figure 42 Medtronic PLC: Company Snapshot
Figure 43 Hologic, Inc.: Company Snapshot

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • C. R. Bard, Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Devicor Medical Products, Inc. (A Part of Leica Biosystems)
  • Argon Medical Devices, Inc.
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Olympus Corporation
  • Boston Scientific Corporation
  • Fujifilm Holdings Corporation
  • Inrad, Inc.
  • Medtronic PLC
  • Hologic, INC.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll